Back to Journals » International Journal of Women's Health » Volume 5
Effectiveness of the cyclic administration of dienogest in a case of pathological disappearance of intestinal endometriosis
Authors Tamura R, Tsuneki I, Yanase T
Received 2 February 2013
Accepted for publication 9 March 2013
Published 16 July 2013 Volume 2013:5 Pages 421—424
DOI https://doi.org/10.2147/IJWH.S43567
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Ryo Tamura, Ikunosuke Tsuneki, Toru Yanase
Department of Obstetrics and Gynecology, Niigata City General Hospital, Niigata, Japan
Abstract: We have reported good control of atypical genital bleeding when using a cyclic administration of dienogest (repeated 4-week cycles, each consisting of the administration of 2 mg/day of dienogest for 3 weeks, followed by 1 week of drug withdrawal) in patients with endometriosis. Herein, we report the effectiveness of the long-term cyclic administration (22 months) of dienogest in a case of pathological disappearance of intestinal endometriosis diagnosed by endoscopy and histology of the lower gastrointestinal tract. There is no recurrent sign after 16 months of the treatment being stopped. Atypical genital bleeding during treatment was 3–5 days a month in each cycle. Compliance was good, so we could continue the therapy. The long-term cyclic administration of dienogest in patients with intestinal endometriosis may have significant merit.
Keyword: atypical genital bleeding, dysmenorrhea, drug compliance, endoscopy, histology
© 2013 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.